Annexin V-FITC Apoptosis Detection BioAssay™ Kit

Referencia 473994-100T

embalaje : 100Tests

Marca : US Biological

Solicitar más información

Contact local distributor :


Teléfono : +1 850 650 7790


473994 Annexin V-FITC Apoptosis Detection BioAssay™ Kit

Clone Type
Polyclonal
Applications
FC
Shipping Temp
Blue Ice
Storage Temp
4°C

Annexin V is a member of a calcium and phospholipid binding family of proteins with vascular anticoagulant activity. Results from in vitro experiments indicate that it may play a role in the inhibition of blood coagulation by competing for phosphatidylserine (PS) binding sites with prothrombin. In healthy cells, PS is usually kept in the inner-leaflet (the cytosolic side) of the cell membrane. When a cell undergoes apoptosis, one of the earliest detectable indicators is the loss of membrane asymmetry. No longer restricted to the cytosolic part of the membrane, PS is translocated to the outer-leaflet and becomes exposed on the surface of the cell.||With our Annexin V-FITC Apoptosis BioAssay™ Kit, we provide a proven method for quickly and easily distinguishing two populations of dying cells from viable cells using Annexin V-FITC and Propidium Iodide (PI) reagents. Cells in the early stages of apoptosis with intact cell membranes and surface -exposed PS will stain positive for Annexin V-FITC. PI is included in the apoptosis assay kit to identify late apoptotic and necrotic cells, which have lost plasma membrane integrity. These cells will become dually labeled with Annexin V-FITC and Propidium Iodide (green and red fluorescence). Live cells with intact plasma membranes will exclude PI and will remain unstained by the Annexin V-FITC probe, assuming no treatment or cell cycle-associated event temporarily exposes the normally internalized, negatively charged PS entity. The BioAssay™ kit also includes a specially formulated, calcium-based binding buffer, which is required for Annexin V binding to occur.||The Annexin V-FITC Apoptosis Detection BioAssay™ Kit detects apoptosis and membrane permability. This in vitro apoptosis assay employs the green fluorescent Annexin V-FITC reagent to label exposed phosphatidylserine in cultured cell samples. Detects membrane compromised cells, a trademark of late apoptosis or cell necrosis, with the live/dead stain, propidium iodide. Analyze the fluorescent signals by Flow Cytometry.||Excitation/Emission:|488nm/530nm||Kit Components:|473994A: Annexin V-FITC, 200X, 1x50ul|473994B; Binding Buffer, 10X, 3x1.7ml|473994C: Propidium Iodide (250ug/ml), 1x 1vial||Storage and Stability:|Store all components at 4°C. Stable for 6 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Applications
Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
References
1. Kerr, J. F., Wyllie, A. H. & Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-257 (1972). 2. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. Chapter 18 Apoptosis: programmed cell death eliminates unwanted cells. 5th Edition edn, (Garland Science, 2008). 3. Schumer, M. et al. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140, 831-838 (1992). 4. Skulachev, V. P. Bioenergetic aspects of apoptosis, necrosis and mitoptosis. Apoptosis 11, 473-485, doi:10.1007/s10495-006-5881-9 (2006). 5. Lowe, S. W. & Lin, A. W. Apoptosis in cancer. Carcinogenesis 21, 485-495 (2000). 6. Mountz, J. D., Wu, J., Cheng, J. & Zhou, T. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 37, 1415-1420 (1994). 7. van Engeland, M., Nieland, L. J., Ramaekers, F. C., Schutte, B. & Reutelingsperger, C. P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31, 1-9 (1998).